Evaluation of the Combination of Romidepsin and Carfilzomib in Relapsed/Refractory Peripheral T Cell Lymphoma Patients

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

July 13, 2015

Primary Completion Date

August 31, 2020

Study Completion Date

September 23, 2021

Conditions
Peripheral T Cell Lymphoma
Interventions
DRUG

Romidepsin

10mg vial for Injection

DRUG

Carfilzomib

60mg vial for injection

Trial Locations (13)

Unknown

Queen Elizabeth Hospital, Birmingham

St James's University Hospital, Leeds

Leicester Royal Infirmary, Leicester

Clatterbridge Cancer Centre, Liverpool

Guy's Hospital, London

St Bartholomew's Hospital, London

University College London Hospitals, London

Christie Hospital, Manchester

Nottingham University Hospitals, Nottingham

Churchill Hospital, Oxford

Derriford Hospital, Plymouth

Southampton General Hospital, Southampton

SM2 5PT

The Royal Marsden NHS Foundation Trust, Sutton

Sponsors

Collaborators (2)

All Listed Sponsors
collaborator

Bloodwise

OTHER

collaborator

Celgene

INDUSTRY

collaborator

Amgen

INDUSTRY

lead

University of Birmingham

OTHER